These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25675639)

  • 1. [Recent epidemiology of pertussis: implications for vaccination].
    Levy J
    Rev Med Brux; 2014 Sep; 35(4):330-4. PubMed ID: 25675639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pertussis vaccine in adolescents and adults].
    Lévy J; Swennen B; Van Laethem Y
    Rev Med Brux; 2004 Sep; 25(4):A229-32. PubMed ID: 15516047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-emergence of pertussis: what are the solutions?
    Libster R; Edwards KM
    Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing pertussis epidemiology: everything old is new again.
    Clark TA
    J Infect Dis; 2014 Apr; 209(7):978-81. PubMed ID: 24626532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
    Yeh SH; Mink CM
    Drugs; 2006; 66(6):731-41. PubMed ID: 16706548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of improved vaccines against whooping cough: current status.
    Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T
    Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis: challenges today and for the future.
    Cherry JD
    PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.
    Skoff TH; Baumbach J; Cieslak PR
    Emerg Infect Dis; 2015 Sep; 21(9):1568-73. PubMed ID: 26291475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.
    Quinn HE; McIntyre PB
    Commun Dis Intell Q Rep; 2007 Jun; 31(2):205-15. PubMed ID: 17724997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
    Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of vaccination on the infectious diseases epidemiology: example of pertussis].
    Guiso N
    Med Sci (Paris); 2007 Apr; 23(4):399-403. PubMed ID: 17433230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for pertussis booster vaccination throughout life in Europe.
    Zepp F; Heininger U; Mertsola J; Bernatowska E; Guiso N; Roord J; Tozzi AE; Van Damme P
    Lancet Infect Dis; 2011 Jul; 11(7):557-70. PubMed ID: 21600850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
    Moraga-Llop FA; Campins-Martí M
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.